IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. - Wikidata - awgldk - TriplyDB

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

http://www.wikidata.org/entity/Q36150469

about

Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.Accurate characterization of the IFITM locus using MiSeq and PacBio sequencing shows genetic variation in Galliformes Rhesus macaque IFITM3 gene polymorphisms and SIV infection.Avian Interferon-Inducible Transmembrane Protein Family Effectively Restricts Avian Tembusu Virus Infection Genome-Wide Search for Host Association Factors during Ovine Progressive Pneumonia Virus Infection Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.Human, Pig, and Mouse Interferon-Induced Transmembrane Proteins Partially Restrict Pseudotyped Lentiviral Vectors.Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.IFITM3 requires an amphipathic helix for antiviral activity.Mechanisms of HIV-1 Control.Interferon-inducible LY6E Protein Promotes HIV-1 Infection.Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins.Polyene macrolide biosynthesis in streptomycetes and related bacteria: recent advances from genome sequencing and experimental studies.Dense Array of Spikes on HIV-1 Virion Particles.The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3.JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1.Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.Alphavirus Restriction by IFITM Proteins Control of HIV infection by IFN-α: implications for latency and a cure.Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins.miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1).Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.Identification of residues controlling restriction versus enhancing activities of IFITM proteins on the entry of human coronaviruses.Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.Interferons and beyond: Induction of antiretroviral restriction factors.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.A CRISPR screen for factors regulating SAMHD1 degradation identifies IFITMs as potent inhibitors of lentiviral particle delivery.Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu.The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3 IFITM proteins inhibit HIV-1 protein synthesis

P2860

Q30145650-14EB3613-054A-4391-9518-86EC9902596D Q30250922-938C5B8B-85DF-4A53-A303-DB6CBD1A1866 Q30361340-B781B829-F604-4685-9FDD-4C3892BBE0ED Q33581241-4C642E84-DC50-4493-BC6F-C365EDA9E65A Q35948010-83AE0019-ABEE-4646-9CCA-21B61CCA7819 Q36039523-CBD02B78-717B-46E4-BC6D-5FC4ECDFFE17 Q36825419-CE66D7B5-4061-4B53-83BC-9CEEC4CA11F8 Q37359047-A4FC5CCD-1EC5-407B-805D-B79512B8EE7B Q38156590-4C5E13F8-0016-46BF-AF0B-B74932F746C2 Q38688274-E90A1D79-86E9-4769-9F60-ECFB7E32571B Q38719032-C7624560-F23F-405A-9A5D-1E4C43AE1345 Q38733780-EE9BDBBD-16C1-4D6F-BF87-95E871546FDB Q38792678-53F44E63-DC01-4831-B8FB-1284FF221977 Q38817990-B085D3F0-20D1-46C7-ABCD-5B1748E79F74 Q39013830-65B3711D-984C-41A6-85BD-10E2EFCE99C5 Q39605419-472401FC-1BD5-4715-9DE2-53F2E62B85FA Q40083618-B4F82D16-D11F-48FE-BEE2-2363D01B7B9B Q40160105-A567C07D-6E06-4BA5-BF9D-F974B2EE21A2 Q40230945-839E5E37-5C2C-4B8A-8F60-BA1FB9A945A1 Q40331435-1A48EFD7-1B22-476D-80E8-6303539CF1F5 Q40385320-0C94E8D2-287E-4174-84EF-DB2C53D0DE3D Q40469216-6585DD89-085A-476A-B1F6-7C6A3F713326 Q40661847-9D8DFD16-F41F-46B8-A523-412DBE83D322 Q41922021-D18AE376-346B-4E35-BC7C-8DFCA9752250 Q41928655-1C86CEC4-E36D-438B-A08F-4619065E93AD Q46197224-3BF365DA-B0E7-487B-8E15-7C91C6E01632 Q47099548-4CFC0F86-E801-4014-82CC-C20B09AE91A0 Q47138132-593639F9-1579-4B1E-8215-747771B5D920 Q47269172-C03E1605-35D3-4529-8A0D-C6E937867E86 Q47550785-5916AEE8-2F7A-40CD-8F05-02F5A277C3E5 Q47552023-FDAD767A-6320-4828-91C2-796D8BA08230 Q47555946-EF678A13-697D-4EB6-BA1D-F916FF845C26 Q52430897-BF57F3E9-1AFA-412B-A03B-820BF2E07C38 Q55034527-2B2A27F8-E9CB-449D-97F9-82AFFAA7C743 Q56967621-84732C02-DD5F-40FB-BF63-D9AEA79AC1D5 Q57292151-41B8B4DD-2C00-484B-BA33-A1253DCB97A4 Q59126216-D499887B-59BF-4254-900E-6247A967DD0E

P2860

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

http://www.wikidata.org/entity/Q36150469

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

@ast

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

@en

type

label

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

@ast

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

@en

prefLabel

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

@ast

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

@en

P1433

Q36150469-2AC70811-9AB6-4B7E-B326-EAE077E5D073

P1476

Q36150469-61F7497C-5004-4C00-9CB3-96D86A5DC0F3

P2093

Q36150469-20F0526E-3264-4C3A-887A-48CDCCF456E7

Q36150469-21369457-AB3C-4600-9D8D-FA88ED0D4D2B

Q36150469-4134B0B0-610C-4868-B828-6D78E306C75D

Q36150469-5B4FF64F-5B9D-4E7B-A2A6-0A09CB0CEC74

Q36150469-8B6DA9EB-326F-4C92-9944-ABEC519C208D

Q36150469-8D14BEC2-6CB8-4B85-A693-4F07F66A067D

Q36150469-B79D6917-8403-4B82-BA6F-5ABA80E553C3

Q36150469-F557C2D9-D42C-42AC-B12C-9A87E028A795

P2860

Q36150469-0929A61E-D4B9-438C-8C6A-F20DFC6A5F5C

Q36150469-162F6F84-4846-4EE8-A7CE-E28B0537B65C

Q36150469-17A2C469-F754-4BA0-91DE-6A4DBF663933

Q36150469-1E8B5DAC-A68D-4AF9-99B4-173F6DEA9570

Q36150469-258AB27D-C873-41D1-A2DE-B376811FC4B4

Q36150469-26D35522-97FA-42B8-8027-7887366ED38A

Q36150469-29E1E02D-A2AB-454F-B23C-E98713B0972A

Q36150469-2FFEAC6D-1766-4E53-BE53-DD374ACBED14

Q36150469-30D3E2AB-D887-45DE-AD06-2FB08308052F

Q36150469-356C25DE-96D4-49CB-ADCB-96C22694DF75

P304

Q36150469-7B5CEA4D-78EE-4802-A2E6-9988005EA884

P31

Q36150469-59C26399-7615-4A83-907D-543D65863E17

P356

Q36150469-1303FC08-C4E7-412B-AE37-828FE95DB958

P433

Q36150469-31429FB4-2006-4E9E-B0B3-316C4D09C921

P478

Q36150469-C1F00D44-D0BB-4D4C-AEFE-D6931ED7537C

P50

Q36150469-9AB9ABA4-9ACB-472B-9E21-8845384B5B3B

Q36150469-A475628C-B866-4AFD-90E3-FAA43E352AD6

Q36150469-DA4A4919-EFB8-4689-B436-519FE89F7A5C

P577

Q36150469-325810BE-8885-4DE1-AE90-07043B90231C

P5875

Q36150469-4132CC56-3ADB-4B8D-86E2-D1C7BCF99B5A

P698

Q36150469-A7BD553B-36C5-4151-AE57-7B9A5CB312F7

P932

Q36150469-699559E1-8B5B-4850-AF67-CAA2FC6025BB

P356

J.CELREP.2015.08.055

P1433

P1476

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein

@en

P2093

Anthony M Esposito

http://www.w3.org/2001/XMLSchema#string

Chen Liang

http://www.w3.org/2001/XMLSchema#string

Eric O Freed

http://www.w3.org/2001/XMLSchema#string

Jingyou Yu

http://www.w3.org/2001/XMLSchema#string

Jordan Wilkins

http://www.w3.org/2001/XMLSchema#string

Minghua Li

http://www.w3.org/2001/XMLSchema#string

Shilei Ding

http://www.w3.org/2001/XMLSchema#string

Yi-Min Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

IFITM proteins restrict viral membrane hemifusion.

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus

MX2 is an interferon-induced inhibitor of HIV-1 infection

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

A diverse range of gene products are effectors of the type I interferon antiviral response

The IFITM proteins inhibit HIV-1 infection

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus

P304

145-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2015.08.055

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin K. Chen

P577

2015-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282049188

http://www.w3.org/2001/XMLSchema#string

P698

26387945

http://www.w3.org/2001/XMLSchema#string

P932

4602366

http://www.w3.org/2001/XMLSchema#string